Text with Title
Distilling analysis from across the pharmaceutical industry into one viewpoint isn’t easy. But it is vital.
Strategic business decisions depend on equity research and forecasts to build a clear view of the market. But there are many equity analysts, and they all have their own opinions. And aggregating those views into a single picture takes time you could be using to draw your own conclusions.
Evaluate can give you back that time.
“ Evaluate's consensus forecasts are the standard at Novartis, and have been for many years. ”
Anthony M., Senior Director, Competitive Intelligence & Prospection, Novartis
“ Evaluate's consensus forecasts are my sole source of forecasts. I don't know where else I could obtain this type of data through a single resource. ”
Katerina S., Information Manager, Zentiva